✦ LIBER ✦

Preservation of ovarian function and minimizing premature ovarian failure during chemotherapy using gonadotropin-releasing hormone analogs

✍ Scribed by Blumenfeld, Zeev

Book ID: 115506057
Publisher: Future Medicine
Year: 2011
Tongue: English
Weight: 278 KB
Volume: 7
Category: Article
ISSN: 1745-5057
DOI: 10.2217/whe.11.72

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ovarian preservation with gonadotropin-r

Ovarian preservation with gonadotropin-releasing hormone analog during chemotherapy

✍ Mitra Modares GILANI; Malihe HASANZADEH; Fatemeh GHAEMMAGHAMI; Fatemeh RAMAZANZA 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

Gonadotropin-releasing hormone analog co

Gonadotropin-releasing hormone analog cotreatment for preservation of ovarian function during gonadotoxic chemotherapy: a systematic review and meta-analysis

✍ Mohamed A. Bedaiwy; Ahmed M. Abou-Setta; Nina Desai; William Hurd; David Starks; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 482 KB

Gonadotropin-releasing hormone analog co

Gonadotropin-releasing hormone analog co-treatment for preservation of ovarian function during gonadotoxic chemotherapy: a systematic review and meta-analysis

✍ M.A. Bedaiwy; A.M. Abou-Setta; N. Desai; W. Hurd; S.A. El-Nashar; T. Falcone 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 34 KB

Use of a gonadotropin-releasing hormone

Use of a gonadotropin-releasing hormone analog for protection against premature ovarian failure during cyclophosphamide therapy in women with severe lupus

✍ Emily C. Somers; Wendy Marder; Gregory M. Christman; Vladimir Ognenovski; W. Jos 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB 👁 2 views

## Abstract ## Objective Cyclophosphamide (CYC) therapy for systemic lupus erythematosus (SLE), a disease predominantly affecting women of childbearing age, causes an unacceptably high incidence of irreversible premature ovarian failure (POF). This study was performed to evaluate the effectiveness

The use of gonadotropin-releasing hormon

The use of gonadotropin-releasing hormone analog in preservation of ovarian function in women undergoing chemotherapy: a systematic review and meta-analysis

✍ M.A. Bedaiwy; S.A. El-Nashar; N. Desai; F.F. Abdel Hafez; A.M. Abdelkader; T. Fa 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 101 KB

Gonadotropin-releasing hormone agonist d

Gonadotropin-releasing hormone agonist decreases chemotherapy-induced gonadotoxicity and premature ovarian failure in young female patients with Hodgkin lymphoma

✍ Zeev Blumenfeld; Irith Avivi; Ari Eckman; Ron Epelbaum; Jacob M. Rowe; Eldad J. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 244 KB